Kids' Weight Loss Drug Use Soars 300-Fold: Is It Safe?

A recent New York University study indicates a dramatic surge in the prescription of GLP-1 medications for weight loss among American children. Since 2019, the number of children taking these drugs has increased approximately 310 times, a trend that surprised researchers.

The study identified that over 20,000 children in the U.S., aged 8 to 11, have been prescribed GLP-1s since 2019. The vast majority, 93.7%, were treated for severe obesity. Interestingly, children in higher-income communities were found to be 55% more likely to receive these prescriptions, even though obesity rates are higher in lower-income areas.

Researchers acknowledge the need for more data on the efficacy and long-term safety of GLP-1s for pediatric use. Experts advise a cautious approach, reminiscent of the principle to avoid being the first to use or prescribe new medications. However, the severe long-term consequences of childhood obesity necessitate treatment, which, according to study authors, must include significant lifestyle modifications like improved diet and exercise, not just medication.